CAS: 1929519-13-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TAK-041 REF: AN-AG0200XHCAS: 1929519-13-0 | 98% | 191.00 €~758.00 € | Tue 21 May 24 |
 | TAK-041 REF: TM-T9317CAS: 1929519-13-0 | 99.49% | 112.00 €~1,388.00 € | Tue 28 May 24 |
 | TAK-041 REF: 3D-ECD51913CAS: 1929519-13-0 | Min. 95% | To inquire | Mon 01 Jul 24 |
Ref: AN-AG0200XH
| 25mg | 191.00 € | |
| 50mg | 217.00 € | |
| 100mg | 459.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
TAK-041
CAS:1929519-13-0
TAK-041 (NBI-1065846) is a potent and selective GPR139 agonist.
Formula:
C18H15F3N4O3
Purity:
99.49%
Color and Shape:
Solid
Molecular weight:
392.33
Ref: TM-T9317
| 1mg | 112.00 € | |
| 5mg | 270.00 € | |
| 10mg | 446.00 € | |
| 25mg | 735.00 € | |
| 50mg | 1,006.00 € | |
| 100mg | 1,388.00 € | |
| 1ml*10 (DMSO) | 297.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
TAK-041
CAS:1929519-13-0
TAK-041 is an analog of a protein that acts as an anticancer agent by inhibiting …
Formula:
C18H15F3N4O3
Purity:
Min. 95%
Molecular weight:
392.3 g/mol
Ref: 3D-ECD51913
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
